{
    "organizations": [],
    "uuid": "047579b8c0af233b1bd7de549b851a9cf2e0cf10",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncosec-medical-announces-proposed/brief-oncosec-medical-announces-proposed-public-offering-of-common-stock-idUSASB0C3BA",
    "ord_in_thread": 0,
    "title": "BRIEF-OncoSec Medical Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - OncoSec Medical Inc:\n* ONCOSEC MEDICAL INCORPORATED ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* ONCOSEC MEDICAL INC - INTENDS TO USE NET PROCEEDS FROM OFFERING PRIMARILY FOR PHASE 2 PISCES/KEYNOTE-695 TRIAL IN MELANOMAâ€‹ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-01T05:19:00.000+02:00",
    "crawled": "2018-02-01T15:16:40.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "oncosec",
        "medical",
        "inc",
        "oncosec",
        "medical",
        "incorporated",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "oncosec",
        "medical",
        "inc",
        "intends",
        "use",
        "net",
        "proceeds",
        "offering",
        "primarily",
        "phase",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}